Literature DB >> 15216222

Intraaortic administration of protamine: Method for heparin neutralization after cardiopulmonary bypass.

Alejandro Aris, Heriberto Solanes, Jose O. Bonnin, Rosa Garin, Jose M. Caralps.   

Abstract

In neutralizing heparin with intravenous protamine sulfate, hypotension may be prevented by administering the drug intraarterially. Forty patients underwent cardiac surgery with extracorporeal circulation in our hospital; each received a rapid injection of nondiluted protamine sulfate in the aortic root to reverse the effects of heparin. To maintain the blood volume at a constant level, volume expanders and inotropic drugs were avoided. The intraaortic injections ranged in duration from 0.2 min to 2.8 min, with a mean of 1.1 min. The mean systolic pressure only dropped from 92 mm Hg (SD +/- 21) before protamine injection to 85 mm Hg (SD +/- 23) after injection (p < 0.0001). In seven patients (18%), no hypotension was evident; in the remaining patients, the systolic pressure returned to preinjection values within a mean of 2.2 min. Coagulation was observed within 3 to 4 min (mean = 2.2 min) after the initiation of injection. This study indicates that intraaortic administration of protamine is a rapid and safe technique for heparin reversal after cardiopulmonary bypass.

Entities:  

Year:  1981        PMID: 15216222      PMCID: PMC287895     

Source DB:  PubMed          Journal:  Cardiovasc Dis        ISSN: 0093-3546


  6 in total

1.  The anti-heparin, anticoagulant and hypotensive properties of hexadimethrine and protamine.

Authors:  W S EGERTON; C L ROBINSON
Journal:  Lancet       Date:  1961-09-16       Impact factor: 79.321

2.  Heparin rebound. Studies in patients and volunteers.

Authors:  N Ellison; C P Beatty; D R Blake; H A Wurzel; H MacVaugh
Journal:  J Thorac Cardiovasc Surg       Date:  1974-05       Impact factor: 5.209

3.  Total cardiopulmonary bypass, myocardial contractility, and the administration of protamine sulfate.

Authors:  A Gourin; R L Streisand; J H Stuckey
Journal:  J Thorac Cardiovasc Surg       Date:  1971-01       Impact factor: 5.209

4.  Cardiovascular effects of protamine sulfate.

Authors:  B S Goldman; J Joison; W G Austen
Journal:  Ann Thorac Surg       Date:  1969-05       Impact factor: 4.330

5.  Protamine sulfate administration and the cardiovascular system.

Authors:  A Gourin; R L Streisand; J K Greineder; J H Stuckey
Journal:  J Thorac Cardiovasc Surg       Date:  1971-08       Impact factor: 5.209

6.  Heparin therapy during extracorporeal circulation. I. Problems inherent in existing heparin protocols.

Authors:  B S Bull; R A Korpman; W M Huse; B D Briggs
Journal:  J Thorac Cardiovasc Surg       Date:  1975-05       Impact factor: 5.209

  6 in total
  3 in total

Review 1.  Anticoagulants in anaesthesia.

Authors:  P J Stow; F A Burrows
Journal:  Can J Anaesth       Date:  1987-11       Impact factor: 5.063

2.  The haemodynamic effects of intraaortic versus intravenous administration of protamine for reversal of heparin in man.

Authors:  B Milne; K Rogers; F Cervenko; T Salerno
Journal:  Can Anaesth Soc J       Date:  1983-07

3.  Administration of Protamine Through Radial Arterial Access: A Prospective Observational Study.

Authors:  Priyanka Goyal; Sandeep Joshi; Monish S Raut
Journal:  Heart Views       Date:  2021-04-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.